| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046429235 |
| P356 | DOI | 10.1038/35041572 |
| P3181 | OpenCitations bibliographic resource ID | 903050 |
| P698 | PubMed publication ID | 11089973 |
| P5875 | ResearchGate publication ID | 12237813 |
| P50 | author | Alessandro Usiello | Q42521253 |
| Roberto Picetti | Q55754954 | ||
| P2093 | author name string | E Borrelli | |
| A Dierich | |||
| M LeMeur | |||
| P V Piazza | |||
| J H Baik | |||
| F Rougé-Pont | |||
| P2860 | cites work | Biphasic effect of D-2 agonist quinpirole on locomotion and movements | Q28256680 |
| Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice | Q28373358 | ||
| Antiproliferative role of dopamine: loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia | Q28508001 | ||
| Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors | Q28512698 | ||
| Dopamine D2 receptor knock-out mice are insensitive to the hypolocomotor and hypothermic effects of dopamine D2/D3 receptor agonists | Q28512882 | ||
| Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice | Q28586296 | ||
| Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors | Q28587334 | ||
| Absence of opiate rewarding effects in mice lacking dopamine D2 receptors | Q28588136 | ||
| Alternative splicing of the dopamine D2 receptor directs specificity of coupling to G-proteins | Q28592318 | ||
| Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations | Q28594346 | ||
| Prominence of the dopamine D2 short isoform in dopaminergic pathways | Q36507451 | ||
| Modulation of neurotransmitter release by presynaptic autoreceptors | Q38357259 | ||
| Mice lacking the norepinephrine transporter are supersensitive to psychostimulants | Q39749651 | ||
| Dopamine receptors: molecular biology, biochemistry and behavioural aspects | Q40604994 | ||
| Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons | Q42484453 | ||
| Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors | Q48172423 | ||
| Lack of autoreceptor-mediated inhibitory control of dopamine release in striatal synaptosomes of D2 receptor-deficient mice | Q48443202 | ||
| Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice | Q48745660 | ||
| Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stress-induced corticosterone secretion. | Q48793285 | ||
| Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum | Q49155446 | ||
| Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons | Q56568482 | ||
| Postsynaptic bimodal effect of sulpiride on locomotor activity induced by pergolide in catecholamine-depleted mice | Q68352827 | ||
| Neuron-specific alternative RNA processing in transgenic mice expressing a metallothionein-calcitonin fusion gene | Q68818586 | ||
| Pharmacological characterization of the receptors involved in the apomorphine-induced polyphasic modifications of locomotor activity in mice | Q72565508 | ||
| Neurobiology of schizophrenia | Q73911147 | ||
| P433 | issue | 6809 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| Dopamine receptor D1 | Q21984178 | ||
| P304 | page(s) | 199-203 | |
| P577 | publication date | 2000-11-09 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Distinct functions of the two isoforms of dopamine D2 receptors | |
| P478 | volume | 408 |
| Q34394954 | A Drosophila dopamine 2-like receptor: Molecular characterization and identification of multiple alternatively spliced variants |
| Q40622353 | A region of the third intracellular loop of the short form of the D2 dopamine receptor dictates Gi coupling specificity |
| Q34135702 | Aberrant regulation of alternative pre-mRNA splicing in schizophrenia |
| Q28591330 | Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine |
| Q34179033 | Addictive genes and the relationship to obesity and inflammation |
| Q45138991 | Adolescent dopamine slows spine maturation |
| Q42154578 | Adolescent stimulation of D2 receptors alters the maturation of dopamine-dependent goal-directed behavior |
| Q64764794 | Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice |
| Q41672253 | Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone |
| Q38065991 | Agonist high- and low-affinity states of dopamine D₂ receptors: methods of detection and clinical implications |
| Q40379505 | Agonist signalling properties of radiotracers used for imaging of dopamine D2/3 receptors |
| Q33859015 | Alcoholism and alternative splicing of candidate genes |
| Q35055022 | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease |
| Q36937690 | Altered dendritic distribution of dopamine D2 receptors and reduction in mitochondrial number in parvalbumin-containing interneurons in the medial prefrontal cortex of cannabinoid-1 (CB1) receptor knockout mice |
| Q44555526 | Alternative splicing of the muscarinic acetylcholine receptor GAR-3 in Caenorhabditis elegans |
| Q35126417 | Amphetamine alters behavior and mesocorticolimbic dopamine receptor expression in the monogamous female prairie vole. |
| Q38973011 | Antagonism of Dopamine D2 Receptors Alters Phosphorylation of Fyn in the Rat Medial Prefrontal Cortex |
| Q36870038 | Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. |
| Q40639740 | Anti-proliferative effects and cell death mediated by two isoforms of dopamine D2 receptors in pituitary tumor cells. |
| Q34306084 | Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. |
| Q37818511 | Antipsychotic occupancy of dopamine receptors in schizophrenia |
| Q39244947 | Aripiprazole, a Drug that Displays Partial Agonism and Functional Selectivity |
| Q30458046 | Assessment between Dopamine Receptor D2 (DRD2) Polymorphisms and Schizophrenia in Korean Population |
| Q45957779 | Association between the DRD2-141C Insertion/Deletion polymorphism and schizophrenia. |
| Q37401604 | Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction |
| Q46513883 | Association of multiple DRD2 polymorphisms with anorexia nervosa |
| Q46422249 | Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients |
| Q37724221 | Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses |
| Q35626928 | Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2. |
| Q47624646 | Behavioral control by striatal adenosine A2A -dopamine D2 receptor heteromers |
| Q28249420 | Biomarkers in the diagnosis of ADHD--promising directions |
| Q48176109 | CASPR2 forms a complex with GPR37 via MUPP1 but not with GPR37(R558Q), an autism spectrum disorder-related mutation |
| Q28074860 | COMT val158met moderation of dopaminergic drug effects on cognitive function: a critical review |
| Q22252698 | Candidate gene studies of ADHD: a meta-analytic review |
| Q48682603 | Cane Toad Skin Extract-Induced Upregulation and Increased Interaction of Serotonin 2A and D2 Receptors via Gq/11 Signaling Pathway in CLU213 Cells |
| Q37104197 | Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex |
| Q43928105 | Case-control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population. |
| Q26743582 | Catecholamines and cognition after traumatic brain injury |
| Q42705179 | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons |
| Q28594153 | Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors |
| Q34466444 | Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems |
| Q39649375 | Chronic ethanol exposure changes dopamine D2 receptor splicing during retinoic acid-induced differentiation of human SH-SY5Y cells |
| Q45072843 | Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. |
| Q47641686 | Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons. |
| Q37983747 | Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism |
| Q46501122 | Cocaine-induced adaptation of dopamine D2S, but not D2L autoreceptors |
| Q37621304 | Common polymorphisms in dopamine-related genes combine to produce a 'schizophrenia-like' prefrontal hypoactivity |
| Q91780889 | Continuous and Discrete Neuron Types of the Adult Murine Striatum |
| Q43868487 | Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. |
| Q28584883 | Contribution of Kv1.2 voltage-gated potassium channel to D2 autoreceptor regulation of axonal dopamine overflow |
| Q34394799 | Control of lactotrop proliferation by dopamine: essential role of signaling through D2 receptors and ERKs |
| Q36851686 | Controlled iontophoresis coupled with fast-scan cyclic voltammetry/electrophysiology in awake, freely moving animals |
| Q61908326 | Correlation between vascular responsivensss and expression of novel transcripts of the ETA-receptor in human vascular tissue |
| Q90054801 | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors |
| Q39109270 | Crosstalk between dopamine D₂ receptors and cannabinoid CB₁ receptors regulates CNR1 promoter activity via ERK1/2 signaling. |
| Q39147170 | Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors |
| Q37807297 | Current perspectives on the selective regulation of dopamine D2 and D3 receptors |
| Q46325348 | D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. |
| Q37416260 | D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons |
| Q42170250 | D3 dopamine autoreceptors do not activate G-protein-gated inwardly rectifying potassium channel currents in substantia nigra dopamine neurons. |
| Q64777182 | DRD2 Genotype-Based Variants Modulates D2 Receptor Distribution in Ventral Striatum |
| Q39017080 | DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia |
| Q50695782 | DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine. |
| Q34508840 | DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia |
| Q33599626 | DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory |
| Q45148113 | Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients |
| Q47985284 | Detection of phasic dopamine by D1 and D2 striatal medium spiny neurons |
| Q46587048 | Differential effects of clozapine and haloperidol on interval timing in the supraseconds range |
| Q34764514 | Differential electrophysiological changes in striatal output neurons in Huntington's disease. |
| Q49645236 | Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms |
| Q40085912 | Differential signaling of dopamine-D2S and -D2L receptors to inhibit ERK1/2 phosphorylation |
| Q39640491 | Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants. |
| Q36075672 | Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium. |
| Q34923951 | Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites |
| Q36162473 | Dopamine D(2) Antagonist-Induced Striatal Nur77 Expression Requires Activation of mGlu5 Receptors by Cortical Afferents |
| Q30496436 | Dopamine D(2) receptor function is compromised in the brain of the methionine sulfoxide reductase A knockout mouse |
| Q43508066 | Dopamine D2 Receptors Modulate Pyramidal Neurons in Mouse Medial Prefrontal Cortex through a Stimulatory G-Protein Pathway |
| Q24312888 | Dopamine D2 receptor activation leads to an up-regulation of glial cell line-derived neurotrophic factor via Gβγ-Erk1/2-dependent induction of Zif268 |
| Q41899842 | Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia. |
| Q46708438 | Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas |
| Q92351278 | Dopamine D2L Receptor Deficiency Causes Stress Vulnerability through 5-HT1A Receptor Dysfunction in Serotonergic Neurons |
| Q41653847 | Dopamine D2L Receptor Is Required for Visual Discrimination and Reversal Learning |
| Q28509965 | Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice |
| Q35570952 | Dopamine agonists in Parkinson’s disease |
| Q35796578 | Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor |
| Q28202607 | Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin |
| Q38111703 | Dopamine and renal function and blood pressure regulation |
| Q28593022 | Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism |
| Q48363479 | Dopamine is involved in food-anticipatory activity in mice |
| Q37076311 | Dopamine modulates risk-taking as a function of baseline sensation-seeking trait |
| Q35000625 | Dopamine receptor autoantibodies correlate with symptoms in Sydenham's chorea |
| Q34438043 | Dopamine receptor functions: lessons from knockout mice [corrected]. |
| Q36391673 | Dopamine receptor repertoire of human granulosa cells |
| Q27021853 | Dopamine signaling in food addiction: role of dopamine D2 receptors |
| Q21129462 | Dopamine signaling in reward-related behaviors |
| Q36593856 | Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction |
| Q24300744 | Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor |
| Q33654916 | Dopamine transporter trafficking: rapid response on demand |
| Q36279518 | Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro |
| Q46419877 | Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil |
| Q39348712 | Dopaminergic Regulation of Innate Immunity: a Review. |
| Q38600504 | Dopaminergic and behavioral changes in a loss-of-imprinting model of Cdkn1c |
| Q35144772 | Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter |
| Q28201520 | Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice |
| Q46013933 | Dose-dependent inverted U-shaped effect of dopamine (D2-like) receptor activation on focal and nonfocal plasticity in humans. |
| Q30423268 | Drosophila Dopamine2-like receptors function as autoreceptors |
| Q30450310 | Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors |
| Q30586693 | Dysfunctional dopaminergic neurotransmission in asocial BTBR mice |
| Q34861234 | Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders |
| Q61814302 | EZH2 Influences mdDA Neuronal Differentiation, Maintenance and Survival |
| Q36850160 | Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia |
| Q28550695 | Effect of C-Terminal S-Palmitoylation on D2 Dopamine Receptor Trafficking and Stability |
| Q48180557 | Effects of Long-Term Alcohol Drinking on the Dopamine D2 Receptor: Gene Expression and Heteroreceptor Complexes in the Striatum in Rats |
| Q33842548 | Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder |
| Q44173422 | Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. |
| Q44396488 | Effects of prenatal exposure to methylmercury on dopamine-mediated locomotor activity and dopamine D2 receptor binding |
| Q57293380 | Effects of social defeat stress on dopamine D2 receptor isoforms and proteins involved in intracellular trafficking |
| Q37161661 | Emotional response in dopamine D2L receptor-deficient mice |
| Q48404644 | Endocytosis following dopamine D2 receptor activation is critical for neuronal activity and dendritic spine formation via Rabex-5/PDGFRβ signaling in striatopallidal medium spiny neurons |
| Q52311700 | Essential Control of the Function of the Striatopallidal Neuron by Pre-coupled Complexes of Adenosine A2A-Dopamine D2 Receptor Heterotetramers and Adenylyl Cyclase. |
| Q31049768 | Evaluation of a structural polymorphism in the ankyrin repeat and kinase domain containing 1 (ANKK1) gene and the activation of executive attention networks |
| Q44135024 | Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake |
| Q30523972 | Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis |
| Q36449651 | Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making. |
| Q93195759 | Functional and molecular heterogeneity of D2R neurons along dorsal ventral axis in the striatum |
| Q45782081 | Functional connectivity in healthy subjects is nonlinearly modulated by the COMT and DRD2 polymorphisms in a functional system-dependent manner. |
| Q82029286 | Functional neurochemistry of the basal ganglia |
| Q37092462 | Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. |
| Q33711011 | Functional variation of the dopamine D2 receptor gene is associated with emotional control as well as brain activity and connectivity during emotion processing in humans |
| Q38672386 | Functions of intrinsic disorder in transmembrane proteins. |
| Q34502401 | G protein-coupled receptors: dominant players in cell-cell communication |
| Q93037037 | GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells |
| Q48139321 | GPR88 in A2A receptor-expressing neurons modulates locomotor response to dopamine agonists but not sensorimotor gating. |
| Q37170603 | Gene-environment interactions affect long-term depression (LTD) through changes in dopamine receptor affinity in Snap25 deficient mice. |
| Q38044428 | Genetic analysis of Parkinson's disease-linked leucine-rich repeat kinase 2. |
| Q37384257 | Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms |
| Q37201805 | Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. |
| Q33533750 | Genetically determined measures of striatal D2 signaling predict prefrontal activity during working memory performance |
| Q37366908 | Getting specialized: presynaptic and postsynaptic dopamine D2 receptors |
| Q37376944 | HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations |
| Q51847137 | Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors. |
| Q39735652 | Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain |
| Q40278018 | Heteromeric nicotinic acetylcholine-dopamine autoreceptor complexes modulate striatal dopamine release. |
| Q38913540 | Hippocampal dysfunction defines disease onset in Huntington's disease |
| Q26995678 | Histamine H₃ receptors, the complex interaction with dopamine and its implications for addiction |
| Q30457477 | How antipsychotics work-from receptors to reality |
| Q33638853 | Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate |
| Q64999981 | Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. |
| Q34671312 | Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1. |
| Q35656487 | Identification of G Protein-Coupled Receptors (GPCRs) in Primary Cilia and Their Possible Involvement in Body Weight Control |
| Q36986026 | Identification of G protein-coupled receptors required for vitellogenin uptake into the oocytes of the red flour beetle, Tribolium castaneum |
| Q43868787 | Identification of a dopamine receptor from Caenorhabditis elegans |
| Q40222308 | Identification of a new functional target of haloperidol metabolite: implications for a receptor-independent role of 3-(4-fluorobenzoyl) propionic acid |
| Q48496117 | Identification of two functionally distinct endosomal recycling pathways for dopamine D₂ receptor. |
| Q57317054 | Imaging genetics in neurodevelopmental psychopathology |
| Q91910583 | Imaging striatal dopamine release using a nongenetically encoded near infrared fluorescent catecholamine nanosensor |
| Q33745451 | Immune-mediated animal models of Tourette syndrome |
| Q28587153 | Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase |
| Q59813705 | In vitro pharmacological characterization of SPN-810M (molindone) |
| Q90141811 | In vivo identification of small molecules mediating Gpr126/Adgrg6 signaling during Schwann cell development |
| Q35250723 | Increased consumption of ethanol and sugar water in mice lacking the dopamine D2 long receptor |
| Q30328388 | Industrial-scale, genomics-based drug design and discovery. |
| Q30497375 | Infralimbic D2 Receptors Are Necessary for Fear Extinction and Extinction-Related Tone Responses |
| Q43805334 | Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. |
| Q36778973 | Insights into the role of dopamine receptor systems in learning and memory |
| Q37958076 | Integrating PET with behavioral neuroscience using RatCAP tomography |
| Q35950814 | Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis |
| Q42048502 | Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity |
| Q48122883 | Intrinsic exercise capacity in rats influences dopamine neuroplasticity induced by physical training. |
| Q34662050 | Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse |
| Q28539688 | Involvement of dopamine D2 receptors in addictive-like behaviour for acetaldehyde |
| Q38709125 | KLF11 is an Epigenetic Mediator of DRD2/Dopaminergic Signaling in Endometriosis |
| Q44350735 | Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms |
| Q37303310 | Kinin Peptides Enhance Inflammatory and Oxidative Responses Promoting Apoptosis in a Parkinson's Disease Cellular Model |
| Q28579950 | Lentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activity |
| Q36599083 | Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome |
| Q33714838 | Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers |
| Q24658338 | Looking for the role of cannabinoid receptor heteromers in striatal function |
| Q42725569 | Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter |
| Q30475378 | Maternal genetic mutations as gestational and early life influences in producing psychiatric disease-like phenotypes in mice |
| Q28217938 | Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive |
| Q30476813 | Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects |
| Q40237744 | Molecular characterization of dopamine D2 receptor isoforms tagged with green fluorescent protein |
| Q43086685 | Molecular cloning of bullfrog D2 dopamine receptor cDNA: Tissue distribution of three isoforms of D2 dopamine receptor mRNA. |
| Q50760658 | Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice. |
| Q35609659 | Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling |
| Q35181211 | NCAM1-TTC12-ANKK1-DRD2 variants and smoking motives as intermediate phenotypes for nicotine dependence |
| Q36353466 | Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults. |
| Q33871737 | Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression? |
| Q30469501 | Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism |
| Q36087867 | Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. |
| Q33785858 | Neurotransmitters in alcoholism: A review of neurobiological and genetic studies. |
| Q36744366 | Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems |
| Q37381378 | Normalizing dopamine D2 receptor-mediated responses in D2 null mutant mice by virus-mediated receptor restoration: comparing D2L and D2S. |
| Q41918764 | Not all partial dopamine D(2) receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse |
| Q37695211 | Novel enhancement mechanism of tyrosine hydroxylase enzymatic activity by nitric oxide through S-nitrosylation |
| Q42248130 | Nucleus accumbens dopamine D2-receptor expressing neurons control behavioral flexibility in a place discrimination task in the IntelliCage |
| Q36747324 | Paradoxical dopaminergic drug effects in extraversion: dose- and time-dependent effects of sulpiride on EEG theta activity |
| Q47399561 | Parallel role for the dopamine D1 receptor in gambling and amphetamine reinforcement in healthy volunteers. |
| Q41831385 | Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons |
| Q36512106 | Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors |
| Q44535579 | Perinatal exposure to delta 9-tetrahydrocannabinol increases presynaptic dopamine D2 receptor sensitivity: a behavioral study in rats |
| Q42164005 | Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase. |
| Q34970259 | PharmGKB summary: dopamine receptor D2 |
| Q34155796 | Pharmacogenetics of antidepressant response |
| Q36730631 | Pharmacogenetics of antiparkinsonian drug treatment: a systematic review. |
| Q30411531 | Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model |
| Q36205868 | Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. |
| Q51358086 | Polymorphisms Falling Within Putative miRNA Target Sites in the 3'UTR Region of SIRT2 and DRD2 Genes Are Correlated With Human Longevity. |
| Q36300098 | Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. |
| Q39635275 | Polypyrimidine tract-binding protein 1 regulates the alternative splicing of dopamine receptor D2 |
| Q41867856 | Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2 |
| Q48250429 | Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice |
| Q35544292 | Presynaptic regulation of dopaminergic neurotransmission |
| Q36838744 | Pro- and anti-mitogenic actions of pituitary adenylate cyclase-activating polypeptide in developing cerebral cortex: potential mediation by developmental switch of PAC1 receptor mRNA isoforms |
| Q34945343 | Protein kinase C beta regulates the D₂-like dopamine autoreceptor. |
| Q36864278 | Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter |
| Q46461062 | Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. |
| Q33238062 | Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation |
| Q35870180 | Psychomotor stimulation by dopamine D₁-like but not D₂-like agonists in most mouse strains |
| Q35097990 | Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood |
| Q41271272 | Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain |
| Q30483115 | R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. |
| Q89517111 | RGS proteins as critical regulators of motor function and their implications in Parkinson's disease |
| Q59802699 | Raman Spectroscopic Analysis of Signaling Molecules–Dopamine Receptors Interactions in Living Cells |
| Q30364690 | Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice. |
| Q28589923 | Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons |
| Q27310687 | Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation |
| Q28593378 | Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan |
| Q28512114 | Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo |
| Q44792301 | Regulation of dopaminergic neuron firing by heterogeneous dopamine autoreceptors in the substantia nigra pars compacta |
| Q33680372 | Regulation of novelty seeking by midbrain dopamine D2/D3 signaling and ghrelin is altered in obesity |
| Q38019926 | Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors |
| Q35107580 | Regulatory roles of heterogeneous nuclear ribonucleoprotein M and Nova-1 protein in alternative splicing of dopamine D2 receptor pre-mRNA. |
| Q89120369 | Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer |
| Q41062561 | Restoring cerebral dopamine homeostasis by electrical forepaw stimulation: an FMRI study |
| Q37592449 | Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders. |
| Q36342934 | Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research |
| Q22252576 | Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis |
| Q42933604 | Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine |
| Q38204258 | Role of dopamine in distal retina |
| Q35014589 | Roles of adrenergic α1 and dopamine D1 and D2 receptors in the mediation of the desynchronization effects of modafinil in a mouse EEG synchronization model |
| Q40624924 | Selection in the dopamine receptor 2 gene: a candidate SNP study |
| Q36010415 | Selective detection of dopamine in the presence of ascorbic acid via fluorescence quenching of InP/ZnS quantum dots |
| Q38243174 | Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. |
| Q34603456 | Signatures of positive selection in genes associated with human skin pigmentation as revealed from analyses of single nucleotide polymorphisms. |
| Q28595051 | Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice |
| Q96348444 | Splice-specific deficiency of the PTSD-associated gene PAC1 leads to a paradoxical age-dependent stress behavior |
| Q43025010 | Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes. |
| Q30443360 | Striatal dopamine D1 receptor is essential for contextual fear conditioning |
| Q34524803 | Striatal dopamine neurotransmission: regulation of release and uptake |
| Q38653197 | Super-resolution Microscopical Localization of Dopamine Receptors 1 and 2 in Rat Hippocampal Synaptosomes. |
| Q48293702 | Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male rats |
| Q48157622 | The Altered Supramolecular Structure of Dopamine D2 Receptors in Disc1-deficient Mice. |
| Q39570856 | The Conserved Arginine Cluster in the Insert of the Third Cytoplasmic Loop of the Long Form of the D₂ Dopamine Receptor (D2L-R) Acts as an Intracellular Retention Signal |
| Q61811625 | The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas |
| Q41534391 | The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo |
| Q53687849 | The balance of PI3K and ERK signaling is dysregulated in prolactinoma and modulated by dopamine. |
| Q34663497 | The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum |
| Q36113801 | The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration |
| Q34463396 | The changing roles and targets for animal models of schizophrenia |
| Q48566256 | The dopamine D2 receptor regulates the development of dopaminergic neurons via extracellular signal-regulated kinase and Nurr1 activation. |
| Q37694353 | The dopamine D4 receptor: biochemical and signalling properties |
| Q33579769 | The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction |
| Q41871692 | The histamine autoreceptor is a short isoform of the H₃ receptor |
| Q35902056 | The impact of alternative splicing in vivo: mouse models show the way. |
| Q100427915 | The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior |
| Q38181840 | The role of D2-autoreceptors in regulating dopamine neuron activity and transmission |
| Q34301403 | The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats |
| Q28591256 | The role of dopamine receptors in regulating the size of axonal arbors |
| Q38100197 | The role of dopamine receptors in the neurotoxicity of methamphetamine. |
| Q90950669 | The striatal-enriched protein Rhes is a critical modulator of cocaine-induced molecular and behavioral responses |
| Q37385718 | Tonic autoinhibition contributes to the heterogeneity of evoked dopamine release in the rat striatum |
| Q42005751 | Two splicing variants of a novel family of octopamine receptors with different signaling properties |
| Q28546441 | Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats |
| Q47304386 | Universal fluorometric aptasensor platform based on water-soluble conjugated polymers/graphene oxide. |
| Q48402642 | Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. |
| Q42201173 | Updated findings of the association and functional studies of DRD2/ANKK1 variants with addictions |
| Q37024867 | Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics |
| Q55216457 | Variations in Dysbindin-1 are associated with cognitive response to antipsychotic drug treatment. |
| Q36015410 | Visualization of the cocaine-sensitive dopamine transporter with ligand-conjugated quantum dots |
| Q27311537 | When chocolate seeking becomes compulsion: gene-environment interplay |
| Q30480496 | Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotype |
| Q35913120 | mRNA transcript diversity creates new opportunities for pharmacological intervention |
Search more.